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Calpains are ubiquitous proteases involved in cell proliferation, adhesion and motility.
In the brain, calpains have been associated with neuronal damage in both acute and
neurodegenerative disorders, but their physiological function in the nervous system
remains elusive. During brain ischemia, there is a large increase in the levels of intracellular
calcium, leading to the activation of calpains. Inhibition of these proteases has been shown
to reduce neuronal death in a variety of stroke models. On the other hand, after stroke,
neural stem cells (NSC) increase their proliferation and newly formed neuroblasts migrate
towards the site of injury. However, the process of forming new neurons after injury is not
efficient and finding ways to improve it may help with recovery after lesion. Understanding
the role of calpains in the process of neurogenesis may therefore open a new window for
the treatment of stroke. We investigated the involvement of calpains in NSC proliferation
and neuroblast migration in two highly neurogenic regions in the mouse brain, the dentate
gyrus (DG) and the subventricular zone (SVZ). We used mice that lack calpastatin, the
endogenous calpain inhibitor, and calpains were also modulated directly, using calpeptin,
a pharmacological calpain inhibitor. Calpastatin deletion impaired both NSC proliferation
and neuroblast migration. Calpain inhibition increased NSC proliferation, migration speed
and migration distance in cells from the SVZ. Overall, our work suggests that calpains
are important for neurogenesis and encourages further research on their neurogenic role.
Prospective therapies targeting calpain activity may improve the formation of new neurons
following stroke, in addition to affording neuroprotection.
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INTRODUCTION
Stroke is currently one of the main causes of brain damage
and long-term disability. For this reason, therapeutic approaches
aiming at repairing the lesion would highly beneficiate patients
with this condition, in addition to providing neuroprotection
against further damage. It is now well established that after the
brain is formed new neurons are still produced throughout the
adult mammalian life in discrete areas of the central nervous
system, an event designated as neurogenesis (Gage, 2000). Neural
stem cells (NSC), which can be found in the subventricular zone
(SVZ) of the lateral ventricles and in the dentate gyrus (DG) of the
Abbreviations: BrdU, 5-bromo-2’-deoxyuridine; Cast+/+, wild type;
Cast−/−, calpastatin knock-out; DCX, doublecortin; DG, dentate gyrus; EdU,
5-ethynyl-2’-deoxyuridine; GZ, granular zone; NeuN, neuronal nuclei; NSC,
neural stem cells; PCNA, proliferating cell nuclear antigen; RMS, rostral
migratory stream; SGZ, subgranular zone; SVZ, subventricular zone.
hippocampus, constitute a pool of cells that exit these proliferative
niches, migrate as neuroblasts towards regions where they are
required and differentiate into mature neurons that integrate the
neuronal circuitry (Aimone et al., 2014). Cells from the SVZ
migrate through the rostral migratory stream (RMS) onto the
olfactory bulbs, and are thought to be responsible for maintaining
and reorganizing the interneuron system in the olfactory bulbs.
In contrast, cells from the DG migrate shorter distances, from
the subgranular zone (SGZ) into the granular zone (GZ) of the
hippocampus, provide a substrate for additional brain plasticity
and are crucial for spatial learning and memory (Imayoshi et al.,
2008). Adult neurogenesis in rodents and other mammals is well
established and has been widely characterized (for review, see
Christian et al., 2014; Jessberger and Gage, 2014; Lim and Alvarez-
Buylla, 2014). In humans, adult neurogenesis was characterized
more recently, particularly in the hippocampus (Spalding et al.,
2013) and in the striatum (Ernst et al., 2014).
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Interestingly, stroke is followed by increased proliferation of
NSC, and new neuroblasts migrate towards the site of injury
(Arvidsson et al., 2002). In humans, there is also evidence
of increased neurogenesis after stroke, even in older patients
(Jin et al., 2006; Macas et al., 2006; Martí-Fàbregas et al.,
2010; Popa-Wagner et al., 2014). Increased neurogenesis likely
represents an endogenous attempt to regenerate cells lost in
lesioned regions (Romanko et al., 2004). However, this process is
limited and ineffective, since few neuroblasts reach the damaged
region. In fact, the majority of the neuroblasts die before
differentiating into functional mature neurons, thus failing the
integration into the neuronal circuitry (Kaneko and Sawamoto,
2009; Ma et al., 2009). Only about 0.2% of dead neurons are
replaced by newly generated neurons, which are not sufficient
to compensate for neurological deficits (Arvidsson et al., 2002).
The study of new strategies to promote post-injury repair
may therefore focus in ways of enhancing neurogenesis in the
adult brain.
After brain damage, the levels of intracellular calcium
dramatically rise due to excitotoxicity, which leads to the
activation of several proteases, including calpains (Neumar
et al., 2001). Calpains are a family of calcium-dependent
proteases that are involved in numerous processes, including
cell adhesion and motility (cytoskeletal/membrane attachments),
signal transduction pathways, cell cycle (proliferation), regulation
of gene expression, apoptosis, and even long-term potentiation
(for review, see Goll et al., 2003). The observed effects of
calpain inhibition may be very different, depending on the cell
type examined. In cell migration, for example, studies have
shown that calpain inhibition impairs the migration ability of
pancreatic beta-cells (Parnaud et al., 2005), vascular smooth
muscle cells (Paulhe et al., 2001), T-cells (Rock et al., 2000),
lung endothelial cells (Qiu et al., 2006), among others; calpain
inhibition also increases the spreading ability of neutrophils
(Lokuta et al., 2003). Moreover, there are also studies that
show either a decrease (Croce et al., 1999) or an increase
(Kuchay et al., 2012) in platelet spreading with the inhibition
of calpains. Therefore, how calpains function in different cells
and which are the signals that trigger their activity remain
unclear.
In the brain, most of the studies regarding calpains focus
on their involvement in neuronal damage. In animal models
of brain ischemia, several calpain inhibitors have shown to be
neuroprotective, being able to reduce neuronal damage caused
by this pathology (Bartus et al., 1994; Hong et al., 1994; Li et al.,
1998; Markgraf et al., 1998; Frederick et al., 2008; Koumura et al.,
2008; Peng et al., 2011). However, there is little information
on the physiological roles of calpains in cells from the central
nervous system. Since calpains can influence cell proliferation
and migration in other systems and NSC also share these
functions, we investigated whether modulation of calpains can
affect neurogenesis. We did this by analyzing the changes in NSC
proliferation and neuroblast migration in the major neurogenic
niches in the brain, the DG and the SVZ. Understanding the
involvement of calpains in the modulation of NSC proliferation
and neuroblast migration may help in the development of new
strategies to improve post-injury brain repair.
RESULTS AND DISCUSSION
To study the effect of calpains on neurogenesis, we modulated
calpain activity using inhibitors. One of the best approaches
available to identify calpain functions in vivo is by altering
the expression of calpastatin (Takano et al., 2005), the only
known endogenous calpain inhibitor (Murachi, 1984). We did
this by using mice lacking calpastatin (Cast−/−). We also used
a pharmacological calpain inhibitor, calpeptin. Migration and
proliferation of NSC in the hippocampus were traced with
different thymidine analogs, as illustrated in Figure 1 and
described in the methods section.
The effect of calpastatin deletion on the proliferation of NSC
in the SGZ of the hippocampus was investigated by administering
a thymidine analog, 5-ethynyl-2’-deoxyuridine (EdU), to both
wild type (Cast+/+) and Cast−/− mice on the day before their
sacrifice. Incorporation of EdU in SGZ cells decreased in Cast−/−
mice (5.7 ± 0.2 cells/section, p = 0.0278) (Figures 2B,C),
when compared to Cast+/+ mice (7.7 ± 0.9 cells/section)
(Figures 2A,C). This shows that proliferation is affected when
calpastatin is absent. In physiological conditions, NSC in the
DG are formed in the SGZ, where they proliferate, and then
migrate as neuroblasts into the GZ (Ming and Song, 2011). Since
the number of EdU-positive cells in the GZ was not altered
(0.4 ± 0.1 cells/section in Cast+/+ and 0.3 ± 0.1 cells/section
in Cast−/−, p = 0.6738) (Figure 2D), the decreased number of
EdU-positive cells observed in the SGZ was probably not due to
enhanced migration into the GZ, supporting the idea of a decrease
in the proliferation caused by loss of calpastatin. Since Sox2
controls NSC maintenance in the hippocampus (Favaro et al.,
2009; Ehm et al., 2010), co-localization of this transcription factor
with either EdU (Figure 2E) or proliferating cell nuclear antigen
(PCNA; Figure 2F) was performed to show that dividing cells
are NSC.
As previously reported, Cast−/− mice do not present increased
intrinsic calpain activity (Takano et al., 2005), but the absence
of calpastatin is expected to deregulate calpain activity, by loss
of inhibition, when calpain activation is needed during cell
proliferation. Suppression of calpain activity has been reported to
reduce the proliferation of different types of cells, such as vascular
smooth muscle cells (Ariyoshi et al., 1998), Chinese hamster ovary
cell colonies (Xu and Mellgren, 2002), osteoblasts (Shimada et al.,
2008), chondrocytes (Kashiwagi et al., 2010) and lung endothelial
cells (Qiu et al., 2006). More recently, the inhibition of calpains
was also shown to decrease the proliferation of mouse NSC lines
(Santos et al., 2012). Different cells may act differently under
different stimuli, so the exact mechanisms through which calpains
FIGURE 1 | Experimental procedure. Cast+/+ and Cast−/− mice were
treated with BrdU for 3 days (every 12 h), and after 7 days with EdU (twice,
2 h apart). The animals were then sacrificed by transcardial perfusion, on
day 12.
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FIGURE 2 | Calpastatin deficiency impairs NSC proliferation in the SGZ.
Representative images from hippocampal brain sections of Cast+/+ (A) and
Cast−/− (B) mice, showing EdU-positive cells in green and nuclei, labeled
with Hoechst 33342, in gray. Number of EdU-positive cells in the SGZ (C) and
the GZ (D) of the hippocampus. Co-localization of EdU (E) or proliferating cell
nuclear antigen (PCNA) (F), in red, with the transcription factor Sox2, in
green; nuclei are labeled with Hoechst 33342, in blue. Scale bars: 40 µm for
(A) and (B); 10 µm for the left panels of (E) and (F); 5 µm for the right panels
of (E) and (F). Means ± SEM of at least 3 independent experiments.
Two-tailed t-test, ∗p < 0.05 (significantly different from Cast+/+).
affect cell proliferation must be studied in further detail, to clarify
these differences.
To analyze whether calpastatin deletion affected the migration
of newly formed NSC in the DG, another thymidine analog, 5-
bromo-2’-deoxyuridine (BrdU), was administered to the mice on
days 9–11 prior to their sacrifice. The analysis of migration in
the DG was performed by three different methods: distribution of
BrdU-positive cells in the SGZ and the GZ, doublecortin (DCX)
immunoreactivity, and distance of BrdU-positive/DCX-positive
cells from the SGZ into the GZ. The number of BrdU-positive
cells in Cast+/+ mice (Figure 3A) was 15.7 ± 4.8 cells/section
in the SGZ (Figure 3C) and 3.3 ± 1.3 cells/section in the
GZ (Figure 3D). In Cast−/− mice (Figure 3B), we observed a
similar distribution of BrdU-positive cells in the DG, with 13.1
± 1.3 cells/section in the SGZ (p = 0.6184, Figure 3C) and 3.4
± 0.5 cells/section in the GZ (p = 0.9329, Figure 3D). While
the analysis of BrdU distribution did not suggest a decreased
number of newborn cells migrating into the GZ of Cast−/−
mice, the overall neuroblast migration in the DG was reduced,
as determined by measuring the percentage of DCX-positive area
(1.5 ± 0.1% in Cast−/− and 2.7 ± 0.3% in Cast+/+, p = 0.0049)
(Figures 4A,B,C). Moreover, BrdU-positive/DCX-positive cells,
which are indicative of migratory newborn cells, presented
shorter migration distances in Cast−/− mice (13.5 ± 0.6 µm,
p = 0.0003) (Figures 4D,F), comparing to Cast+/+ mice (20.8
± 1.1 µm) (Figures 4D,E). These results suggest an impairment
of neuroblast migration in the DG of calpastatin-deficient mice,
in addition to decreased NSC proliferation. Moreover, this effect
on neuroblast migration was not limited to the DG, we also
observed an impairment of cell migration in the RMS of Cast−/−
mice (1899.9 ± 575.3 µm2, p = 0.0039) (Figures 5B,C), when
compared toCast+/+mice (4259.2± 764.8µm2) (Figures 5A,C).
Frontiers in Cellular Neuroscience www.frontiersin.org February 2015 | Volume 9 | Article 22 | 3
Machado et al. Calpains, stroke and adult neurogenesis
FIGURE 3 | Calpastatin deficiency does not alter the distribution of
BrdU-positive cells in the DG. Representative images from hippocampal
brain sections of Cast+/+ (A) and Cast−/− (B) mice, showing BrdU-positive
cells in green and nuclei, labeled with NeuN, in gray. Number of
BrdU-positive cells in the SGZ (C) and the GZ (D) of the hippocampus.
Scale bar: 40 µm. Means ± SEM of 5 independent experiments. Two-tailed
t-test, p > 0.05.
Calpains have been shown to be involved in the migration of
a variety of cell types, particularly by regulating cell spreading,
speed and adherence, focal contact formation, filopodial and
lamellipodial protusion formation and chemokinesis, with the
involvement of signaling proteins such as Rac1, RhoA, Cdc42 and
phospholipase C (Potter et al., 1998; Croce et al., 1999; Paulhe
et al., 2001; Lokuta et al., 2003; Parnaud et al., 2005; Kuchay
et al., 2012). Even though calpain inhibition results in decreased
migration for most cell types already studied, there are reports
showing that calpain inhibition increases the spreading ability
of neutrophils (Lokuta et al., 2003) and, more recently, platelets
(Kuchay et al., 2012). Although further research is needed to
better understand the physiological roles of calpains, the results
here presented suggest that promoting calpain activation may
impair the formation of newborn neuronal cells, by interfering
with the first stages of neurogenesis.
Excitotoxicity after stroke activates calpains, and several
studies have already demonstrated that calpain inhibition is
effective in reducing brain damage in animal models of this
pathology. If calpain inhibition could enhance post-injury
neurogenesis in addition to providing neuroprotection, it could
be a potential therapeutic option to reduce brain damage after
stroke. In this context, we investigated the effect of calpain
inhibition on NSC proliferation and neuroblast migration in
culture, using the calpain inhibitor calpeptin. Cell proliferation, as
analyzed by EdU incorporation (Figure 6A), was lower inCast−/−
cells (24.2 ± 0.9%) than in Cast+/+ cells (28.4 ± 1.0%), which is
consistent with our in vivo observations. Calpeptin reversed this
effect (29.7± 0.8%, p< 0.01), indicating that calpains may in fact
be mediating cell proliferation. Moreover, calpeptin also increased
cell proliferation in Cast+/+ cells (32.0 ± 0.7%, p < 0.05). With
the goal of enhancing post-injury neurogenesis, this slight rather
FIGURE 4 | Calpastatin deficiency decreases DCX
immunoreactivity and migration distance of newborn cells in the
DG. Representative images from hippocampal brain sections of
Cast+/+ (A) and (E) and Cast−/− (B) and (F) mice, showing migrating
neuroblasts in red, labeled for DCX, and BrdU-positive cells in green.
Percentage of DCX immunoreactivity in the DG (C). Distance migrated
from the SGZ by the BrdU-positive/DCX-positive cells present in the
GZ (D). Co-localization of BrdU and DCX is shown in the right panels of
(E) and (F). Scale bars: 100 µm for (A) and (B); 20 µm for (E) and (F).
Means ± SEM of at least 3 independent experiments. Two-tailed
t-test, **p < 0.01 and ***p < 0.001 (significantly different from
Cast+/+).
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FIGURE 5 | Calpastatin deficiency decreases DCX immunoreactivity in
the RMS. Representative images from sagittal striatal brain sections of
Cast+/+ (A) and Cast−/− (B), showing migrating neuroblasts in gray,
labeled for DCX. OB, olfactory bulb. DCX-positive area in the RMS (C).
Scale bar: 200 µm. Means ± SEM of 5 independent experiments.
Two-tailed t-test, *p < 0.05 (significantly different from Cast+/+).
than high increase in cell proliferation is actually preferable,
since it lowers the risk of undifferentiated mass growth, while
still somewhat increasing the number of newborn cells that may
later on replace lost neurons. Nevertheless, increasing neuroblast
migration and consequent neuronal differentiation, integration
and survival is important for successfully improving brain repair
after stroke.
Finally, we also assessed cell migration in SVZ explants isolated
from wild type mice. Calpeptin (Figure 6C) increased both the
migration speed (16.0 ± 0.8 µm/h, p = 0.0063) (Figure 6D)
and the migration distance (943.0 ± 51.9 µm, p = 0.0120)
(Figure 6E) of cells leaving the explants, when compared to
untreated cells (migration speed 12.0 ± 0.8 µm/h; migration
distance 715.0 ± 50.2 µm) (Figures 6B,D,E). This translates into
another advantage for the potential use of calpain inhibition
to enhance post-injury neurogenesis, i.e., improving migration.
However, studies on how calpain inhibition may affect neuronal
differentiation, integration and survival are still needed in order
to corroborate the idea of using calpain inhibitors to treat brain
damage after stroke.
Calpains are key players in the neuronal damage that occurs
after stroke (Bano and Nicotera, 2007; Bevers and Neumar, 2008).
For this reason, some of the strategies that have been developed in
order to limit neuronal death after ischemic lesion have focused
on interfering with calpain function. Several calpain inhibitors
were already shown to be neuroprotective in animal models of
brain ischemia (Bartus et al., 1994; Hong et al., 1994; Li et al.,
1998; Markgraf et al., 1998; Frederick et al., 2008; Koumura
et al., 2008; Peng et al., 2011). Furthermore, overexpression of
calpastatin (Cao et al., 2007) and calpain silencing (Bevers et al.,
2010) have also been shown to be effective in reducing neuronal
death caused by stroke. The results presented here show that
the lack of calpastatin hinders proliferation of NSC in the SGZ
FIGURE 6 | Calpain inhibition increases NSC proliferation and cell
migration in Cast+/+ cells and rescues cell proliferation in Cast−/−
cells. Percentage of living cells positive for EdU (A). Representative images
of SVZ explants untreated (B) or with calpeptin 25 µM (C). Migration speed
(D) and radius (E) of cells migrating out of the SVZ explants. Means ± SEM
of at least 3 independent experiments. Two-way ANOVA (Bonferroni’s
post-test) (A) or two-tailed t-test (D) and (E), *p < 0.05 and **p < 0.01
(significantly different from control). Scale bar: 100 µm.
of the hippocampus, as well as migration of newborn cells into
the GZ and in the RMS of adult mice. Moreover, we show that
calpain inhibition increases SVZ-derived NSC proliferation and
cell migration in wild type cells. We propose that, in addition to
their neuroprotective effect, the use of calpain inhibitors results in
an enhancement of post-injury brain repair. This constitutes an
added benefit for potential clinical application for the treatment
of stroke. Neuroprotection afforded by inhibition of calpains was
also observed in other pathologies in which calpains contribute
to the neuronal damage. These include traumatic brain injury
(Saatman et al., 1996; Schoch et al., 2012), Alzheimer’s disease
(Rao et al., 2008), Parkinson’s disease (Crocker et al., 2003), spinal
cord injury (Ray et al., 2000), diabetic retinopathy (Shanab et al.,
2012), acute optic neuritis (Das et al., 2013) and optic nerve crush
(Araujo Couto et al., 2004).
Stem cells offer a promising approach for brain repair
after stroke. In addition to the enhancement of endogenous
neurogenesis, other approaches recently reported include
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transplantation after stroke of NSC obtained from human fetal
brain (Mine et al., 2013), induced pluripotent stem cells (Tornero
et al., 2013) or stem cells from other origins (for review, see
Lindvall and Kokaia, 2011; Hermann et al., 2014; Ikegame
et al., 2014). Directly inducing the conversion of astrocytes
into neurogenic cells is also being regarded as a possibility for
post-injury brain repair (Niu et al., 2013; Magnusson et al.,
2014). However, these approaches are currently hampered
by limited cell survival due to the unfavorable conditions
present in the lesioned areas. Such unfavorable conditions
seem to be particularly worsened with age, conditioning the
outcome of brain repair, partly by reducing the natural increase
of endogenous neurogenesis (Popa-Wagner et al., 2014).
Nonetheless, stem cell therapies have also shown to at least
partially improve recovery after stroke in aged rodents (Jin et al.,
2010; Zhang et al., 2013; Balseanu et al., 2014; Tatarishvili et al.,
2014). Thus, combined therapies pose a promising approach to
enhance post-injury brain repair, both in young and aged brains.
Overall, inhibiting calpains may improve the outcome of brain
repair strategies based on cell therapy by both limiting neuronal
damage and enhancing neurogenesis.
MATERIAL AND METHODS
ANIMALS
Twenty-week old calpastatin knock-out mice (Cast−/−, n = 5)
(Takano et al., 2005), in a C57Bl6 background, and their wild
type littermates (Cast+/+, n = 5), were used in this study. The
mice were kept in our animal facilities, in a room with controlled
temperature (21 ± 1◦C) and humidity (55%), with food and
water ad libitum in a 12 h dark:light cycle. All experiments
were performed in accordance with institutional and European
guidelines (2010/63/EU) for the care and use of laboratory
animals.
LABELING OF DIVIDING CELLS WITH THYMIDINE ANALOGS
The experimental procedure was conducted as illustrated in
Figure 1. Briefly, the animals (5 Cast−/− and 5 Cast+/+) were
treated for 3 days with BrdU (Sigma Aldrich, St Louis, MO, USA),
through i.p. injections of 50 mg/kg every 12 h. After 7 days,
EdU was administrated (Invitrogen, Paisley, UK), through i.p.
injections of 50 mg/kg, twice, 2 h apart. This was performed in
order to assess cell migration and cell proliferation, respectively.
On day 12, the mice were perfused transcardially with 0.9 % NaCl
followed by 4 % paraformaldehyde. The brains were removed
and coronal hippocampal sections and sagittal striatal sections
were obtained by cryosectioning (30 µm thick, in 6-series). The
sections were stored in an antifreeze solution, at 4◦C.
IMMUNOHISTOCHEMISTRY AND DETECTION OF THYMIDINE ANALOGS
Free-floating coronal hippocampal sections were processed for
immunohistochemistry against BrdU, DCX and neuronal nuclei
(NeuN), or double-labeled against PCNA and Sox2, or EdU and
Sox2. DNA denaturation for BrdU staining was performed by
treating the sections with 1 M HCl for 20 min at 65◦C. Antigen
retrieval for Sox2 or PCNA stainings was performed by treating
the sections with 10 mM citric acid, pH 6.0, for 20 min at
95◦C. The sections were then blocked for 1 h with 5 % normal
horse or goat serum (Vector Laboratories Inc., Burlingame, CA,
USA), respectively, in 0.25 % Triton X-100 in 0.01 M PBS.
Slices were incubated with the primary antibodies, mouse anti-
BrdU (1:80; DAKO, Glostrup, Denmark) or rat anti-BrdU (1:50,
AbD Serotec, Oxford, UK), goat anti-DCX (1:400; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), mouse anti-NeuN (1:200;
Millipore Corporation, Billerica, MA, USA), mouse anti-PCNA
(1:50; Santa Cruz Biotechnology, Santa Cruz, CA, USA) or rabbit
anti-Sox2 (1:250; Millipore Corporation, Billerica, MA, USA)
for 48 h at 4◦C. The sections were then incubated with the
correspondent secondary antibody (1:200), in 2 % block (normal
horse or goat serum, accordingly), conjugated with Alexa Fluor
488, Alexa Fluor 594 or Alexa Fluor 633 (Invitrogen, Paisley, UK),
for 2 h in the dark, at room temperature. Labeling for EdU was
performed by click-chemistry with Alexa Fluor 488 or 594 azide,
according to the manufacturer instructions (Invitrogen, Paisley,
UK) and, with the exception of the BrdU staining, nuclei were
stained with Hoechst 33342 (2 µg/ml; Invitrogen, Paisley, UK)
for 10 min. Free-floating sagittal striatal sections were stained
against DCX. The sections were mounted on gelatin-coated slides
with DAKO fluorescence mounting medium (DAKO, Glostrup,
Denmark).
ANALYSIS OF INCORPORATION OF BrdU AND EdU
BrdU-positive and EdU-positive cells in the SGZ, the first layer
of cells adjacent to the hilus, and in the GZ of 5 mid sections of
the hippocampus (spanning 180 µm of the dorsal hippocampus)
were counted for each animal (Liu et al., 1998; Brunson et al.,
2001; Salazar-Colocho et al., 2008; Kim et al., 2009; Carreira et al.,
2010), directly under an epifluorescence microscope (Axioskop
2 Plus, Zeiss, Jena, Germany), by one blinded observer. Cell
counting was carried out in both upper and lower blades
of the DG.
DCX IMMUNOREACTIVITY AND MIGRATION MEASUREMENTS IN THE
DG
DCX immunoreactivity in the DG and migration distances of
BrdU-positive/DCX-positive cells in the GZ were determined
in images acquired in a laser scanning microscope (LSM 510
Meta, Zeiss, Jena, Germany), using ImageJ (version 1.43u,
National Institutes of Health, Bethesda, MD, USA) with the
LSM Toolbox Plugin. The quantification of the DCX-positive
area was performed using a threshold analysis in 5 mid sections
of the hippocampus of each animal. This consisted in defining
the optimal threshold for stained vs. non stained cells and
calculating the area stained with DCX (Komitova et al., 2005;
Carreira et al., 2010). The migration measurements, in turn,
were performed in a total of approximately 30 cells from
5 images acquired for each Cast+/+ or Cast−/− mouse, by
determining the distance between the nucleus of the cell and the
boundary between the SGZ and the hilus, perpendicularly to that
delimitation.
DCX IMMUNOREACTIVITY IN THE RMS
DCX immunoreactivity in the RMS was determined using
ImageJ (version 1.43u, National Institutes of Health, Bethesda,
MD, USA), in images acquired in an inverted microscope
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(Axio Observer Z1, Zeiss, Jena, Germany), using the Mosaix
module from the AxioVision software Rel. 4.8.2 (Zeiss, Jena,
Germany), in order to capture the entire RMS on each section.
DCX-positive area was measured for each image in 3 boxes of 250
µm × 250 µm, randomly placed along the length of the RMS,
a method similar to what was previously described (Kuhn et al.,
1997).
NSC PROLIFERATION IN SVZ CULTURES
NSC were isolated from the SVZ of P0-3 Cast+/+ and Cast−/−
mice and maintained in culture, as previously described (Morte
et al., 2013). Dissociated NSC (n = 3) were plated on coverslips
coated with 0.1 mg/ml poly-L-lysine (Sigma Aldrich, St Louis,
MO, USA) until 60–70% confluency was reached, and then
treated with calpeptin 25 µM (Tocris Bioscience, Bristol, UK)
for 6 h (untreated cells were used as controls). The cells
were kept with EdU 10 µM for the last 4 h before fixation
with 4% paraformaldehyde/4% sucrose. EdU incorporation was
processed using a commercially available kit (Click-iTrEdU
Alexa Fluorr488 HCS Assay, Invitrogen, Paisley, UK) and nuclei
were stained with 1 µg/ml Hoechst 33342, for 5 min. EdU-
positive cells were counted in images acquired in an Axio Imager
Z2 microscope (Zeiss, Jena, Germany).
NSC MIGRATION SVZ EXPLANTS
SVZ explants were prepared from wild type C57Bl6 mice
(P5–7) and cultured for 72 h in 70% Matrigel (BD Biosciences,
San Jose, CA, USA) in CCM1 medium (Hyclone, Logan, UT,
USA) supplemented with 1% Pen/Strep and 1% B27 (Invitrogen,
Paisley, UK) (Wichterle et al., 1997; de Chevigny et al., 2006),
in the presence (n = 5) or absence (n = 8) of calpeptin 25 µM.
Migration distances were measured in 5 explants per culture and
migrating cells were imaged for 3 h, at 3 min intervals, under an
Eclipse TE200 inverted microscope (Nikon Corporation, Tokyo,
Japan), using the Metamorph 6.3v1 software (Molecular Devices,
Sunnyvale, CA, USA), in order to calculate the migration speed of
cells leaving the explants.
STATISTICAL ANALYSIS
The data are presented as means ± SEM. Statistical significance
was determined using a two-tailed t-test or a two-way ANOVA, as
indicated in the figure legends, using GraphPad Prism 5 software.
Differences were considered significant when p< 0.05.
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